EUVIMEDEUVIMED entdecken
Open Access

15-PGDH inhibition enhances hematopoietic regeneration during aging

Rahul Chaudhary iD, Brittany A Cordova, Marcus Hong, Bailey R Klein, Lyannah A Contreras, Ritisha Rashmil, Filip Goshevski, Julianne N P Smith, Derek J Taylor, Andrew A Pieper, Sanford Markowitz, Amar B Desai iD

Stem Cells · 17.09.2025 · 43 (10)

DOI: 10.1093/stmcls/sxaf047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells, online erschienen am 04.07.2025. Verfasst von Rahul Chaudhary und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Case Western Reserve University, Cleveland, OH io44106, United States. Hauptthemen laut MEDLINE: Aging, Hematopoietic Stem Cells, Hematopoiesis, Hydroxyprostaglandin Dehydrogenases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematopoietic aging is characterized by diminished stem cell regenerative capacity and an increased risk of hematologic dysfunction. We previously identified that the prostaglandin-degrading enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) regulates hematopoietic stem cell (HSC) activity. Here, we expand on this work and demonstrate that in aged mice: (1) 15-PGDH expression and activity remain conserved in the bone marrow (BM) and spleen, suggesting that it remains a viable therapeutic target in aging; (2) prolonged PGDH inhibition (PGDHi) significantly increases the frequency and number of phenotypic hematopoietic stem and progenitor cells across multiple compartments, with transcriptional changes indicative of enhanced function; (3) PGDHi-treated BM enhances short-term hematopoietic recovery following transplantation, leading to improved peripheral blood output and accelerated multilineage reconstitution; and (4) PGDHi confers a competitive advantage in primary hematopoietic transplantation while mitigating age-associated myeloid bias in secondary transplants. Notably, these effects occur without perturbing steady-state blood production, suggesting that PGDHi enhances hematopoiesis under regenerative conditions while maintaining homeostasis. Our work identifies PGDHi as a translatable intervention to rejuvenate aged HSCs and mitigate hematopoietic decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingHematopoietic Stem CellsHematopoiesisHydroxyprostaglandin DehydrogenasesRegenerationAnimalsMiceMice, Inbred C57BLHematopoietic Stem Cell Transplantation

Stichwörter der Autor:innen

agingdrug targethematopoietic stem cell transplantationhematopoietic stem cellsstem cells

Substanzen

15-hydroxyprostaglandin dehydrogenaseHydroxyprostaglandin Dehydrogenases

Autor:innen und Institutionen

  • Department of Medicine, Case Western Reserve University, Cleveland, OH io44106, United States.
  • Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH io44106, United States.
  • Department of Pharmacology, Case Western Reserve University, Cleveland, OH io44106, United States.
  • Brain Health Medicines Center, Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland, OH io44106, United States.
  • Department of Psychiatry, Case Western Reserve University, Cleveland, OH io44106, United States.
  • Geriatric Psychiatry, GRECC, Louis Stokes VA Medical Center, Cleveland, OH io44106, United States.

ORCID-Profile: Rahul Chaudhary, Amar B Desai

Förderung

  • NIH HHS
  • National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health
  • NIGMS NIH HHS
  • NCI NIH HHS
  • Valour Foundation, as the Rebecca E. Barchas, MD, University Professor in Translational Psychiatry of Case Western Reserve University
  • NCATS NIH HHS
  • NIDDK Innovative Science Accelerator Program
  • NHLBI NIH HHS

Zitieren

APA

Chaudhary, R., Cordova, B. A., Hong, M., Klein, B. R., Contreras, L. A., Rashmil, R., Goshevski, F., Smith, J. N. P., Taylor, D. J., Pieper, A. A., Markowitz, S., & Desai, A. B. (2025). 15-PGDH inhibition enhances hematopoietic regeneration during aging. Stem Cells, 43(10). https://doi.org/10.1093/stmcls/sxaf047

Vancouver

Chaudhary R, Cordova BA, Hong M, Klein BR, Contreras LA, Rashmil R, et al. 15-PGDH inhibition enhances hematopoietic regeneration during aging. Stem Cells. 2025;43(10). doi:10.1093/stmcls/sxaf047

BibTeX
@article{Chaudhary2025,
  author = {Chaudhary, Rahul and Cordova, Brittany A and Hong, Marcus and Klein, Bailey R and Contreras, Lyannah A and Rashmil, Ritisha and Goshevski, Filip and Smith, Julianne N P and Taylor, Derek J and Pieper, Andrew A and Markowitz, Sanford and Desai, Amar B},
  title = {15-PGDH inhibition enhances hematopoietic regeneration during aging},
  journal = {Stem Cells},
  year = {2025},
  volume = {43},
  number = {10},
  doi = {10.1093/stmcls/sxaf047}
}
Kostenlos starten →